Literature DB >> 31995680

Mortality Reduction with Low-Dose CT Screening for Lung Cancer.

Stephen W Duffy1, John K Field1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31995680     DOI： 10.1056/NEJMe1916361

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  MicroRNA-133a-3p suppresses malignant behavior of non-small cell lung cancer cells by negatively regulating ERBB2.

Authors:  Yanhui Xu; Lei Zhang; Lilong Xia; Xinhai Zhu
Journal:  Oncol Lett       Date:  2021-04-08       Impact factor: 2.967

Review 2.  Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives.

Authors:  Matthijs Oudkerk; ShiYuan Liu; Marjolein A Heuvelmans; Joan E Walter; John K Field
Journal:  Nat Rev Clin Oncol       Date:  2020-10-12       Impact factor: 66.675

Review 3.  The challenges of implementing low-dose computed tomography for lung cancer screening in low- and middle-income countries.

Authors:  Eduardo Edelman Saul; Raquel B Guerra; Michelle Edelman Saul; Laercio Lopes da Silva; Gabriel F P Aleixo; Raquel M K Matuda; Gilberto Lopes
Journal:  Nat Cancer       Date:  2020-11-30

4.  Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American Populations.

Authors:  Jian Carrot-Zhang; Giovanny Soca-Chafre; Nick Patterson; Aaron R Thorner; Anwesha Nag; Jacqueline Watson; Giulio Genovese; July Rodriguez; Maya K Gelbard; Luis Corrales-Rodriguez; Yoichiro Mitsuishi; Gavin Ha; Joshua D Campbell; Geoffrey R Oxnard; Oscar Arrieta; Andres F Cardona; Alexander Gusev; Matthew Meyerson
Journal:  Cancer Discov       Date:  2020-12-02       Impact factor: 38.272

5.  What is the balance of benefits and harms for lung cancer screening with low-dose computed tomography?

Authors:  Stephen H Bradley; Bethany Shinkins; Martyn Pt Kennedy
Journal:  J R Soc Med       Date:  2021-03-10       Impact factor: 5.344

6.  Targeting lung cancer screening to individuals at greatest risk: the role of genetic factors.

Authors:  Mikey B Lebrett; Emma J Crosbie; Miriam J Smith; Emma R Woodward; D Gareth Evans; Philip A J Crosbie
Journal:  J Med Genet       Date:  2021-01-29       Impact factor: 6.318

7.  A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil.

Authors:  Adalberto Miranda-Filho; Hadrien Charvat; Freddie Bray; Arn Migowski; Li C Cheung; Salvatore Vaccarella; Mattias Johansson; Andre L Carvalho; Hilary A Robbins
Journal:  EClinicalMedicine       Date:  2021-11-01

8.  Study on the Prediction Method of Long-term Benign and Malignant Pulmonary Lesions Based on LSTM.

Authors:  Xindong Liu; Mengnan Wang; Rukhma Aftab
Journal:  Front Bioeng Biotechnol       Date:  2022-03-02

9.  COL8A1 Promotes NSCLC Progression Through IFIT1/IFIT3-Mediated EGFR Activation.

Authors:  Xiangyi Zan; Shuyan Li; Shixiong Wei; Liping Gao; Lanting Zhao; Xiaoxia Yan; Yan Zhao; Junnian Shi; Yuping Wang; Rong Liu; Yuanyi Zhang; Yixin Wan; Yongning Zhou
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

10.  A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancer.

Authors:  Daniel Ajona; Ana Remirez; Cristina Sainz; Cristina Bertolo; Alvaro Gonzalez; Nerea Varo; María D Lozano; Javier J Zulueta; Miguel Mesa-Guzman; Ana C Martin; Rosa Perez-Palacios; Jose Luis Perez-Gracia; Pierre P Massion; Luis M Montuenga; Ruben Pio
Journal:  Transl Res       Date:  2021-02-19       Impact factor: 7.012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.